(PharmaNewsWire.Com, June 20, 2017 ) According to Publisher, the Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%. Rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market.
Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients. North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector.
Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Novo Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terumo Corporation and Teva Pharmaceutical Industries Ltd.
Therapeutic Applications Covered: - Autoimmune Diseases o Crohn's Disease o Multiple Sclerosis o Psoriasis o Rheumatoid Arthritis o Other Autoimmune Diseases - Hormonal Disorders o Anaemia o Antithrombotic/Thrombolytic Therapy o Diabetes o Growth Hormone Deficiency (GHD) o Osteoporosis o Reproductive Health Disease - Orphan Diseases - Oncology - Other Therapeutic Applications o Pain Management o Allergy Treatment o Aesthetic Treatments o Hepatitis C o Haemophilia
End-Users Covered: - Home Care Settings - Hospitals and Clinics - Pharmaceutical and Biotechnology Companies - Research Laboratories - Other End Users
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
